Abstract
Inflammatory bowel disease (IBD) is a chronic disease of the gastrointestinal tract that affects men and women in their young and reproductive years of life. Anxieties about potentially harmful medication, the effect of pregnancy on disease, the effect of disease on the fetus, and the potential of passing on of disease to offspring result in a relatively high “voluntary” childlessness in young women with IBD. A careful consultation with the parents-to-be on these justified concerns is necessary and involves a proactive approach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adrulonis R, Ferris LK (2012) Treatment of severe psoriasis with ustekinumab during pregnancy. J Drugs Dermatol 11(10):1240–1241
Alsenaid A, Prinz JC (2016) Inadvertant pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis. JEADV 30:488–490
Angelberger S, Reinisch W, Messerschmidt A et al (2011) Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 5(2):95–100
Ban L, Tata LJ, Fiaschi L et al (2014) Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology 146(1):76–84
Barclay AR, Russell RK, Wilson ML et al (2009) Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 155:421–426
Beaulieu DB, Ananthakrishnan AN, Issa M et al (2009) Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis 15(1):25–28
Ben-Horin S, Yavzori M, Katz L et al (2010) Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol Hepatol 8(5):475–476
Ben-Horin S, Yavzori M, Kopylov U et al (2011) Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. J Crohns Colitis 5(6):555–558
Bennett RA, Rubin PH, Present DH (1991) Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 100:1638–1643
Bergstrand O, Hellers G (1983) Breast-feeding during infancy in patients who later develop Crohn’s disease. Scand J Gastroenterol 18:903–906
Beyer-Berjot L, Maggiori L, Birnbaum D et al (2013) A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg 258(2):275–282
de Boer NK, Jarbandhan SV, de Graaf P et al (2006) Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 101(6):1390–1392
Carmichael SL, Shaw GM, Ma C et al (2007) Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 197(6):585.e1–585.e7 discussion 683–4, e1–7
Casanova MJ, Chaparro M, Domenech E et al (2013) Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol 108(3):433–440
Clowse ME, Wolf DC, Forger F et al (2015) Pregnancy outcomes in subjects exposed to Certolizumab Pegol. J Rheumatol 42(12):2270–2278
Coelho J, Beaugerie L, Colombel JF et al (2011) Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME study. Gut 60(2):198–203
Cornish JA, Tan E, Teare J et al (2007) The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 50(8):1128–1138
van der Woude CJ, Ardizzone S, Bengtson MB et al (2015) The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis 9(2):107–124
Diav-Citrin O, Park YH, Veerasuntharam G et al (1998) The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114:23–28
Gardiner SJ, Gearry RB, Roberts RL et al (2006) Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 62(4):453–456
Gotestam Skorpen C, Hoeltzenbein M, Tincani A et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795–810
Habal FM, Hui G, Greenberg GR (1993) Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 105:1057–1060
Hernandez-Diaz S, Su YC, Mitchell AA et al (2013) Medications as a potential source of exposure to phthalates among women of childbearing age. Reprod Toxicol 37:1–5
Homar V, Grosek S, Battelino T (2008) High-dose methylprednisolone in a pregnant woman with Crohn’s disease and adrenal suppression in her newborn. Neonatology 94(4):306–309
Hudson M et al (1997) Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 58:229–237
Hviid A, Molgaard-Nielsen D (2011) Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 183:796–804
Jurewicz J, Hanke W (2011) Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies. Int J Occup Med Environ Health 24(2):115–141
Kane SV, Acquah LA (2009) Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 104(1):228–233
Kanis SL, de Lima-Karagiannis A, de Boer NK, van der Woude CJ (2017) Use of thiopurines during conception and pregnancy not associated with adverse pregnancy outcomes or health of infants at 1 year in a prospective study. Clin Gastroenterol Hepatol 15(8):1232–1241.e1
Kozlowski RD, Steinbrunner JV, Mackenzie AH et al (1990) Outcome of 1st-trimester exposure to low-dose methotrexate in 8 patients with rheumatic disease. Am J Med 88:589–592
de Lima A, Zelinkova Z, Mulders AG et al (2016a) Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol 14(9):1285–1292
de Lima A, Zelinkova Z, van der Ent C et al (2016b) Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety. Gut 65(8):1261–1268
Lin K, Martin CF, Dassopoulos T et al (2014) Pregnancy outcomes amongst mothers with inflammatory bowel disease exposed to systemic corticosteroids: results of the PIANO registry [abstract]. Gastroenterology 146:S1
Mahadevan U, Martin CF, Sandler RS et al (2012) PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with ibd exposed to immunomodulators and biologic therapy. Gastroenterology 142:S149
Mahadevan U, Vermeire S, Lasch K et al (2017) Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Aliment Pharmacol Ther 45(7):941–950
Mahadevan UMC, Sandler RS (2014) Achievement of developmental milestones among offspring of women with inflammatory bowel disease: the PIANO registry. Gastroenterology 146:S-1
Martel MJ, Rey E, Beauchesne MF et al (2005) Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ 330(7485):230
Martin PL, Sachs C, Imai N et al (2010) Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation. Birth Defects Res B Dev Reprod Toxicol 89(5):351–363
Nguyen GC, Seow CH, Maxwell C et al (2016) The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 150(3):734–757
Norgard B, Czeizel AE, Rockenbauer M et al (2001) Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 15:483–486
Orholm M, Fonager K, Sorensen HT (1999) Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol 94:3236–3238
Ost L, Wettrell G, Bjorkhem I et al (1985) Prednisolone excretion in human milk. J Pediatr 106:1008–1011
Park-Wyllie L, Mazzotta P, Pastuszak A et al (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385–392
Rahimi R, Nikfar S, Rezaie A et al (2008) Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 25(2):271–275
Rajaratnam SG, Eglinton TW, Hider P et al (2011) Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Color Dis 26(11):1365–1374
Rocha K, Piccinin MC, Kalache LF et al (2015) Pregnancy during ustekinumab treatment for severe psoriasis. Dermatology 231(2):103–104
Sheeran C, Nicolopoulos J (2014) Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester. Australas J Dermatol 55(3):235–236
Shim L, Eslick GD, Simring AA et al (2011) The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohns Colitis 5(3):234–238
Smithells RW, Newman CGH (1992) Recognition of thalidomide defects. J Med Genet 29:716–723
Takeda (2014) Vedolizumab (Entyvio) package insert. Takeda, Cambridge Available from: http://www.general.takedapharm.com
Waljee A, Waljee J, Morris AM et al (2006) Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 55(11):1575–1580
Zelinkova Z, de Haar C, de Ridder L et al (2011) High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther 33(9):1053–1058
Zelinkova Z, van der Ent C, Bruin KF, van Baalen O, Vermeulen HG, Smalbraak HJ et al (2013) Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol 11(3):318–321
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
van der Giessen, J., van der Woude, C.J. (2019). Fertility, Pregnancy, and Lactation. In: Sturm, A., White, L. (eds) Inflammatory Bowel Disease Nursing Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-75022-4_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-75022-4_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75021-7
Online ISBN: 978-3-319-75022-4
eBook Packages: MedicineMedicine (R0)